Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

19.10
Delayed Data
As of Jan 12
 +0.60 / +3.24%
Today’s Change
7.75
Today|||52-Week Range
25.70
+14.71%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close18.50
Today’s open18.55
Day’s range18.30 - 19.30
Volume727,105
Average volume (3 months)1,358,648
Market cap$1.4B
Data as of 4:00pm ET, 01/12/2018

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-45.39%
Earnings growth (next 5 years)+12.23%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
AKCAAkcea Therapeutics I...-0.21-1.22%
INVAInnoviva Inc+0.01+0.07%
FWPForward Pharma A/S+0.07+1.61%
PCRXPacira Pharmaceutica...-0.73-1.72%
Data as of 4:00pm ET, 01/12/2018

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)$0.11
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts